Recent News

July 06, 2020

AASM Patient Guides Available

The American Academy of Sleep Medicine has developed patient guides for several clinical practice guidelines. Patients can use these to help identify what questions to ask their physician and understand diagnosis and treatment options.
June 15, 2020

Noctrix Health granted FDA Breakthrough Device Designation for wearable Restless Legs Syndrome Therapy

Noctrix Health, Inc., a privately held medical device company announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its wearable NTX100 Neuromodulation therapy designed for the treatment of adults with primary moderate-seve...
June 08, 2020

Eisai Announces U.S. Availability of DAYVIGO® (lemborexant) CIV, a New Treatment Option for Adults With Insomnia

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced the availability of DAYVIGO® (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance